ATEZOLIZUMAB - Food and Drug Administration

Manufacturer: Food and Drug Administration
Effective date: 2025-03-31
Label type: Indexing - product concept
Version: 1
Source: full-release
Hydrated at: 2026-06-05 00:25:37

Label at a glance#

ProductATEZOLIZUMAB

Active ingredientATEZOLIZUMAB, HYALURONIDASE (HUMAN RECOMBINANT)

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 2 matching rows.

ATEZOLIZUMAB
HYALURONIDASE (HUMAN RECOMBINANT)

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 2 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
ATEZOLIZUMAB	52CMI0WC3Y	ACTIB
HYALURONIDASE (HUMAN RECOMBINANT)	743QUY4VD8	ACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
TECENTRIQ	ATEZOLIZUMAB	Genentech, Inc.	6fa682c9-a312-4932-9831-f286908660ee	2026-05-20	Warnings, Adverse reactions	Name fallback generic name: ATEZOLIZUMAB

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.